All In Biotech

Free tool

FAERS Monitor: Salagen

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020237 or its brand name (Salagen, Pilocarpine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,485

Serious

1,537

62% of reports

Hospitalization

686

Death reported

101

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective223
  • headache199
  • pain195
  • fatigue187
  • nausea174
  • off label use154
  • dyspnoea149
  • arthralgia141
  • dizziness130
  • fall127
  • diarrhoea124
  • cough117
  • malaise105
  • weight increased101
  • eye pain100

Reports by year received

View as table
YearReports
200460
200562
200638
200734
200851
200973
201088
201155
201268
201377
201477
2015100
2016105
2017123
2018112
2019141
2020167
2021140
2022176
2023160
2024178
2025228
2026172

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,674 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
eye painSignal10015.012.41,297
weight increasedSignal1013.83.2209
coughSignal1173.53.0213
fallSignal1273.22.7196
arthralgiaSignal1412.92.4173
painSignal1952.72.3211
headacheSignal1992.72.4215
dyspnoeaSignal1492.21.9102
dizzinessSignal1302.21.987
fatigueSignal1872.01.8101
malaiseSignal1052.01.755
nausea1741.91.671
diarrhoea1241.61.430
off label use1541.51.325
drug ineffective2231.41.331

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.